BCTX
Price
$2.91
Change
-$0.02 (-0.68%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
19.91M
VKTX
Price
$28.19
Change
+$0.47 (+1.70%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
3.11B
20 days until earnings call
Interact to see
Advertisement

BCTX vs VKTX

Header iconBCTX vs VKTX Comparison
Open Charts BCTX vs VKTXBanner chart's image
Briacell Therapeutics Corp NEW
Price$2.91
Change-$0.02 (-0.68%)
Volume$825
Capitalization19.91M
Viking Therapeutics
Price$28.19
Change+$0.47 (+1.70%)
Volume$95.57K
Capitalization3.11B
BCTX vs VKTX Comparison Chart in %
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCTX vs. VKTX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a Hold and VKTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (BCTX: $2.94 vs. VKTX: $27.72)
Brand notoriety: BCTX and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 35% vs. VKTX: 114%
Market capitalization -- BCTX: $19.87M vs. VKTX: $3.11B
BCTX [@Biotechnology] is valued at $19.87M. VKTX’s [@Biotechnology] market capitalization is $3.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than BCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • BCTX’s TA Score: 4 bullish, 4 bearish.
  • VKTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than BCTX.

Price Growth

BCTX (@Biotechnology) experienced а +0.34% price change this week, while VKTX (@Biotechnology) price change was +2.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

BCTX is expected to report earnings on Jun 16, 2025.

VKTX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.11B) has a higher market cap than BCTX($19.9M). VKTX YTD gains are higher at: -31.113 vs. BCTX (-65.664). BCTX has higher annual earnings (EBITDA): -27.19M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. BCTX (5.01M). BCTX has less debt than VKTX: BCTX (27K) vs VKTX (1M). BCTX (0) and VKTX (0) have equivalent revenues.
BCTXVKTXBCTX / VKTX
Capitalization19.9M3.11B1%
EBITDA-27.19M-171.93M16%
Gain YTD-65.664-31.113211%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.01M852M1%
Total Debt27K1M3%
FUNDAMENTALS RATINGS
BCTX vs VKTX: Fundamental Ratings
BCTX
VKTX
OUTLOOK RATING
1..100
8463
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
10075
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
9364
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (40) in the Biotechnology industry is somewhat better than the same rating for BCTX (96) in the null industry. This means that VKTX’s stock grew somewhat faster than BCTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (75) in the Biotechnology industry is in the same range as BCTX (100) in the null industry. This means that VKTX’s stock grew similarly to BCTX’s over the last 12 months.

VKTX's SMR Rating (91) in the Biotechnology industry is in the same range as BCTX (100) in the null industry. This means that VKTX’s stock grew similarly to BCTX’s over the last 12 months.

VKTX's Price Growth Rating (64) in the Biotechnology industry is in the same range as BCTX (93) in the null industry. This means that VKTX’s stock grew similarly to BCTX’s over the last 12 months.

BCTX's P/E Growth Rating (1) in the null industry is significantly better than the same rating for VKTX (100) in the Biotechnology industry. This means that BCTX’s stock grew significantly faster than VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCTXVKTX
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 22 days ago
80%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HFFG3.340.09
+2.77%
HF Foods Group
CWAN22.140.37
+1.70%
Clearwater Analytics Holdings
VRAR1.350.02
+1.50%
Glimpse Group (The)
METC11.94-0.07
-0.58%
Ramaco Resources
LYB62.01-0.55
-0.88%
LyondellBasell Industries NV

BCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCTX has been loosely correlated with TAOX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BCTX jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
-0.68%
TAOX - BCTX
35%
Loosely correlated
+5.20%
KROS - BCTX
34%
Loosely correlated
+0.30%
MDGL - BCTX
30%
Poorly correlated
-0.43%
AXON - BCTX
30%
Poorly correlated
+2.70%
LSB - BCTX
30%
Poorly correlated
-2.44%
More